CGM supplies are the consumable and semi-durable parts that keep a continuous glucose monitor running, typically including the sensor, the transmitter, and the reader or smartphone app. Understanding the CGM supplies required by each system helps you budget, plan wear schedules, and avoid coverage gaps between sensor changes.
The Three Core Components
Every CGM system in the United States follows a similar architecture. A small filament under the skin measures interstitial fluid glucose. A radio transmitter sends readings to a display device every 1 to 5 minutes. A reader or smartphone app converts that stream into trend graphs, alarms, and reports.
What varies across brands is how the components are packaged. Older systems such as Dexcom G6 used a disposable sensor plus a reusable transmitter. Newer systems such as Dexcom G7 and Freestyle Libre 3 integrate the transmitter into the sensor, simplifying the supplies list but shortening overall wear time per unit.
Sensor Wear Time and Replacement Cadence
Sensor wear time is the single biggest driver of CGM supply costs. The table below compares current systems.
| System | Sensor Wear | Transmitter | Reader Option | Over the Counter |
|---|---|---|---|---|
| Dexcom G7 | 10 days plus 12 hour grace | Integrated | Receiver or smartphone | No |
| Dexcom Stelo | 15 days | Integrated | Smartphone app only | Yes |
| Freestyle Libre 3 | 14 days | Integrated | Smartphone or Libre reader | No |
| Freestyle Libre 3 Plus | 15 days | Integrated | Smartphone or Libre reader | No |
| Abbott Lingo | 14 days | Integrated | Smartphone app only | Yes |
| Eversense E3 | 180 days, implanted | Removable on-body | Smartphone | No |
| Medtronic Guardian 4 | 7 days | Reusable, 1 year life | Pump or smartphone | No |
Accessory Supplies Most Users Add
Beyond the manufacturer core kit, real-world wearers often stock additional items.
- Adhesive overpatches from brands like Skin Grip, Simpatch, or Stayput help sensors survive 10 to 15 days of showering and exercise.
- Alcohol prep wipes and skin barrier products such as Skin-Tac or Cavilon improve initial adhesion.
- Medical adhesive removers such as Uni-Solve reduce skin trauma on removal.
- Extra applicators and caps are useful when traveling.
- Rechargers or spare batteries for receiver-based systems.
Prescription Versus Over-the-Counter Pathways
Before 2024, every CGM in the United States required a prescription. The FDA clearance of Dexcom Stelo in March 2024 and Abbott Lingo later that year opened an over-the-counter pathway aimed at adults without diabetes or those with type 2 diabetes who are not on insulin. OTC products are sold online or through select retailers and do not require a clinician order. They also do not currently qualify for insurance or Medicare coverage.
Prescription CGMs remain the standard for people on insulin and for those with documented episodes of problematic hypoglycemia. If you are exploring whether to use a CGM as part of prediabetes treatment, talk with your clinician about whether a short OTC trial or a prescription system fits your goals.
Coverage and Cost Considerations
Medicare Part B currently covers therapeutic CGMs for beneficiaries with diabetes using insulin or with a history of problematic hypoglycemia. Supplies are billed as durable medical equipment through approved suppliers. Commercial insurance coverage varies widely by plan, with many plans routing CGM supplies through the pharmacy benefit rather than the durable medical equipment benefit.
Without insurance, monthly costs fall roughly in these ranges:
- Dexcom G7: about 180 to 280 dollars per month of sensors
- Freestyle Libre 3: about 140 to 220 dollars per month of sensors
- Dexcom Stelo or Abbott Lingo OTC: about 89 to 99 dollars per month
- Eversense E3 implanted sensor: about 1,400 to 1,700 dollars per 180-day period, exclusive of professional insertion
Storage and Handling
Most CGM sensors should be stored between 36 and 86 degrees Fahrenheit. Freezing can damage the enzymatic coating on the sensor wire. High humidity and direct sunlight shorten adhesive shelf life. Do not open the sterile applicator packaging until ready to apply.
Failed sensors are not uncommon. Manufacturers typically offer replacement if a sensor fails early, but you must report failures through the app or customer service within specified windows. Keeping one backup sensor on hand prevents data gaps during travel or supply shipment delays.
Practical Tips for New Users
A few habits separate smooth CGM use from frustrating troubleshooting.
- Rotate insertion sites to prevent scar tissue, which can produce inaccurate readings.
- Apply sensors to clean, dry skin after showering rather than before.
- Avoid applying over tattoos, moles, stretch marks, or areas with heavy scarring.
- Calibrate when prompted if your system requires it, using a fingerstick meter for comparison. Reviewing prediabetes basics can help you interpret CGM trend lines in context.
- Do not rely on sensor readings alone for medication dosing until you understand the system’s typical lag and accuracy profile.
When CGM Data Matters Most
CGM supplies pay off when data drives behavior change. Reviewing ambulatory glucose profile reports with a clinician every 30 to 90 days is the most common workflow. Short-term, two-week wear during lifestyle experiments often yields actionable information about meal choices, timing of exercise, sleep, and stress.
The Bottom Line
CGM supplies include three main categories of items: sensors, transmitters where not integrated, and readers or compatible smartphones. Wear time determines replacement cadence and cost. Over-the-counter options now exist for adults not on insulin, while prescription systems continue to dominate clinical use. The FDA glucose monitoring device overview and your insurance’s formulary are the best first stops for confirming coverage. Discuss with your clinician which system fits your treatment plan and whether CGM wear is appropriate for your situation.
This article is for educational purposes only and does not constitute medical advice. Always consult your healthcare provider for diagnosis and treatment decisions.